Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study
Benjamin A Fisher, Antonia Szanto, Wan-Fai Ng, Michele Bombardieri, Maximilian G Posch, Athena S Papas, Arwa M Farag, Thomas Daikeler, Bettina Bannert, Diego Kyburz, Alan J Kivitz, Steven E Carsons, David A Isenberg, Francesca Barone, Simon J Bowman, Pascal Espié, David Floch, Cyrielle Dupuy, Xiaohui Ren, Petra M Faerber, Andrew M Wright, Hans-Ulrich Hockey, Michael Rotte, Julie Milojevic, Alexandre Avrameas, Marie-Anne Valentin, James S Rush, Peter Gergely
Source record
Source: Crossref
Published: Mar 1, 2020
DOI: 10.1016/s2665-9913(19)30135-3
Open original source ↗Evidence graph
No public relationships recorded yet.
Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.